U.S. president Donald Trump's announcement of "very, very high rate" of tariffs on pharmaceutical goods has sent ripples through Canberra, with both sides of politics expressing their concern.
BreakdownGenerated by LeadStory AI
- The US plans to impose tariffs up to 200% on imported pharmaceuticals. 7s
- Australia exported over $2 billion in pharmaceuticals to the US last year. 34s
- Industry warns tariffs could impact patient access to new medicines in Australia. 48s
- US companies claim Australia's PBS scheme disadvantages them in the market. 1m 12s
- Australian government refuses to use the PBS as a bargaining chip in negotiations. 1m 23s
See The Full Story

Global Tariffs
Donald Trump has signed an order to impose tariffs imports into the U.S. from countries including China, Mexico and Canada.